US 11,873,502 B2
Transgenic plants with enhanced traits
Edwards M. Allen, O'Fallon, MO (US); Bettina Darveaux, Hillsborough, NC (US); Stephen M. Duff, St. Louis, MO (US); Mary Fernandes, St. Louis, MO (US); Barry S. Goldman, St. Louis, MO (US); Cara L. Griffith, Catawissa, MO (US); Balasulojini Karunanandaa, Creve Coeur, MO (US); Saritha V Kuriakose, Kottayam (IN); Paul J. Loida, Kirkwood, MO (US); Linda L Lutfiyya, St. Louis, MO (US); Robert J. Meister, St. Peters, MO (US); Monnanda S. Rajani, Chesterfield, MO (US); Dhanalakshmi Ramachandra, Bangalore (IN); Elena A. Rice, Olivette, MO (US); Daniel Ruzicka, St. Louis, MO (US); Anagha M. Sant, St. Louis, MO (US); Jon J. Schmuke, St. Louis, MO (US); Rebecca L. Thompson, St. Charles, MO (US); Srikanth Babu Venkatachalayya, Bangalore (IN); Tyamagondlu V. Venkatesh, St. Louis, MO (US); Huai Wang, Chesterfield, MO (US); Xiao Yang, St. Charles, MO (US); Qin Zeng, Chesterfield, MO (US); and Jianmin Zhao, St. Louis, MO (US)
Assigned to Monsanto Technology LLC, St. Louis, MO (US)
Filed by Monsanto Technology LLC, St. Louis, MO (US)
Filed on Mar. 14, 2022, as Appl. No. 17/694,370.
Application 17/694,370 is a division of application No. 16/085,527, abandoned, previously published as PCT/US2017/022617, filed on Mar. 16, 2017.
Claims priority of provisional application 62/310,136, filed on Mar. 18, 2016.
Prior Publication US 2022/0195452 A1, Jun. 23, 2022
Int. Cl. A01H 5/10 (2018.01); C12N 15/00 (2006.01); C12N 15/82 (2006.01)
CPC C12N 15/8273 (2013.01) [A01H 5/10 (2013.01); C12N 15/00 (2013.01); C12N 15/825 (2013.01); C12N 15/8213 (2013.01); C12N 15/8218 (2013.01)] 14 Claims
 
1. A monocot plant comprising and expressing a recombinant DNA construct, wherein the recombinant DNA construct comprises:
a) a polynucleotide sequence having at least 95% sequence identity to the nucleotide sequence of SEQ ID NO:21; or
b) a polynucleotide sequence that encodes a polypeptide having an amino acid sequence having at least 95% sequence identity to the amino acid sequence of SEQ ID NO:50;
wherein the recombinant DNA construct further comprises a heterologous promoter operably linked to the polynucleotide sequence,
wherein the plant has been selected for having an altered phenotype as compared to a control plant, and wherein the altered phenotype is selected from the group consisting of increased kernels per row, increased kernels per ear, increased ear area, increased ear length, increased ear diameter, and increased single kernel weight.